Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 19-11-2024
NAV ₹37.42(R) +0.84% ₹40.09(D) +0.83%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 47.67% 23.2% 30.05% -% -%
LumpSum (D) 48.92% 24.29% 31.28% -% -%
SIP (R) 19.17% 34.29% 28.06% -% -%
SIP (D) 20.25% 35.44% 29.2% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.03 0.59 0.96 6.33% 0.17
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.02% -17.15% -14.27% 0.89 10.1%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option 23.8
0.1900
0.8000%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option 26.17
0.2200
0.8500%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 37.42
0.3100
0.8400%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option 40.09
0.3300
0.8300%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed six return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: Three return parameters of the Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund are in the top 25% in the category, as shown below:
      • 1Y Return %
      • 3Y Return %
      • 5Y Return %
    2. Above Average Below the Top 25%: The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has two return parameters in the category, which are above average but below the top 25%, as shown below:
      • 3M Return %
      • 6M Return %
    3. Below Average: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has one return parameter that is below average in the category, which is listed below:
      • 1M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: two risk parameters in the lowest 25% in the category, which are listed below.
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.02 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.1 %.
    2. Below Average but Above the Lowest 25%: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has four risk-adjusted performance parameters of the fund that are in the top 25% of the category.
      • Sharpe Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sharpe Ratio of 1.03 compared to the category average of 0.85.
      • Sterling Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sterling Ratio of 0.96 compared to the category average of 0.78.
      • Sortino Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sortino Ratio of 0.59 compared to the category average of 0.47.
      • Treynor Ratio: Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Treynor Ratio of 0.17 compared to the category average of 0.14.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.31
-3.29
-6.13 | -1.38 8 | 13 Good
3M Return % 2.02
1.96
-4.87 | 6.68 8 | 13 Good
6M Return % 20.17
18.30
11.91 | 24.73 5 | 13 Good
1Y Return % 47.67
42.10
34.98 | 50.25 2 | 11 Very Good
3Y Return % 23.20
19.81
16.87 | 23.20 1 | 8 Very Good
5Y Return % 30.05
27.82
23.59 | 30.75 2 | 8 Very Good
1Y SIP Return % 19.17
11.42
-16.11 | 26.02 3 | 11 Very Good
3Y SIP Return % 34.29
29.69
26.71 | 34.29 1 | 8 Very Good
5Y SIP Return % 28.06
25.28
22.04 | 28.06 1 | 8 Very Good
Standard Deviation 15.02
15.31
14.31 | 15.96 2 | 8 Very Good
Semi Deviation 10.10
10.45
10.03 | 10.78 2 | 8 Very Good
Max Drawdown % -14.27
-16.50
-18.92 | -14.27 1 | 8 Very Good
VaR 1 Y % -17.15
-16.74
-18.91 | -14.68 5 | 8 Average
Average Drawdown % -4.23
-5.03
-7.25 | -3.98 4 | 8 Good
Sharpe Ratio 1.03
0.85
0.66 | 1.10 2 | 8 Very Good
Sterling Ratio 0.96
0.78
0.66 | 0.96 1 | 8 Very Good
Sortino Ratio 0.59
0.47
0.36 | 0.59 1 | 8 Very Good
Jensen Alpha % 6.33
3.31
-0.30 | 7.34 2 | 8 Very Good
Treynor Ratio 0.17
0.14
0.11 | 0.19 2 | 8 Very Good
Modigliani Square Measure % 24.99
21.86
18.21 | 26.49 2 | 8 Very Good
Alpha % 4.22
1.69
-1.06 | 4.46 2 | 8 Very Good
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.23 -3.19 -6.01 | -1.30 8 | 13
3M Return % 2.24 2.29 -4.48 | 7.04 8 | 13
6M Return % 20.68 19.06 12.84 | 25.80 6 | 13
1Y Return % 48.92 43.86 36.19 | 52.14 2 | 11
3Y Return % 24.29 21.27 18.64 | 24.29 1 | 8
5Y Return % 31.28 29.43 25.54 | 32.68 2 | 8
1Y SIP Return % 20.25 12.87 -14.86 | 27.66 3 | 11
3Y SIP Return % 35.44 31.23 28.48 | 35.44 1 | 8
5Y SIP Return % 29.20 26.80 23.81 | 29.20 1 | 8
Standard Deviation 15.02 15.31 14.31 | 15.96 2 | 8
Semi Deviation 10.10 10.45 10.03 | 10.78 2 | 8
Max Drawdown % -14.27 -16.50 -18.92 | -14.27 1 | 8
VaR 1 Y % -17.15 -16.74 -18.91 | -14.68 5 | 8
Average Drawdown % -4.23 -5.03 -7.25 | -3.98 4 | 8
Sharpe Ratio 1.03 0.85 0.66 | 1.10 2 | 8
Sterling Ratio 0.96 0.78 0.66 | 0.96 1 | 8
Sortino Ratio 0.59 0.47 0.36 | 0.59 1 | 8
Jensen Alpha % 6.33 3.31 -0.30 | 7.34 2 | 8
Treynor Ratio 0.17 0.14 0.11 | 0.19 2 | 8
Modigliani Square Measure % 24.99 21.86 18.21 | 26.49 2 | 8
Alpha % 4.22 1.69 -1.06 | 4.46 2 | 8
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.84 ₹ 10,084.00 0.83 ₹ 10,083.00
1W -1.78 ₹ 9,822.00 -1.79 ₹ 9,821.00
1M -3.31 ₹ 9,669.00 -3.23 ₹ 9,677.00
3M 2.02 ₹ 10,202.00 2.24 ₹ 10,224.00
6M 20.17 ₹ 12,017.00 20.68 ₹ 12,068.00
1Y 47.67 ₹ 14,767.00 48.92 ₹ 14,892.00
3Y 23.20 ₹ 18,701.00 24.29 ₹ 19,200.00
5Y 30.05 ₹ 37,197.00 31.28 ₹ 38,998.00
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 19.17 ₹ 13,216.68 20.25 ₹ 13,283.35
3Y ₹ 36000 34.29 ₹ 58,619.45 35.44 ₹ 59,506.42
5Y ₹ 60000 28.06 ₹ 119,908.80 29.20 ₹ 123,180.66
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Regular Growth Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Direct Growth
19-11-2024 37.42 40.09
18-11-2024 37.11 39.76
14-11-2024 37.55 40.23
13-11-2024 37.44 40.1
12-11-2024 38.1 40.82
11-11-2024 38.47 41.22
08-11-2024 38.71 41.46
07-11-2024 38.81 41.57
06-11-2024 39.18 41.96
05-11-2024 38.71 41.46
04-11-2024 38.45 41.18
31-10-2024 38.6 41.34
30-10-2024 37.97 40.66
29-10-2024 38.09 40.79
28-10-2024 38.26 40.97
25-10-2024 37.76 40.44
24-10-2024 38.08 40.77
23-10-2024 37.87 40.54
22-10-2024 38.06 40.75
21-10-2024 38.7 41.43

Fund Launch Date: 25/Jun/2018
Fund Category: Pharma Fund
Investment Objective: To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Fund Description: An Open Ended Equity Scheme following Pharma, Healthcare, Diagnostic and allied Theme
Fund Benchmark: S&P BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.